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ERRATUM  
The following passages must be amended: 
1. page 23, addition of a citation in Figure 7: Production and structure of oxidized 
phospholipids and its components (modified after Ashraf & Srivastava, 2010; Bochkov 
et al. 2010). 
2. page 24, addition of a citation in Figure 8: Anti-inflammatory effects and mechanisms 
of OxPL (Bochkov et al. 2010). 
OxPL mediate a diverse spectrum of bioactivities. For instance, OxPL are involved in the 
inhibition of lipopolysaccharide-induced activation of toll-like receptors (Bochkov et al., 2010).  
Furthermore, OxPL are suggested to assume a role in acute inflammation (sepsis or acute 
lung injury) (Imai et al., 2008), neurodegenerative diseases like Alzheimer´s or Parkinson´s 
and chronic inflammation (Furnkranz et al., 2005; Usui et al., 2009). The peroxidation of 
phospholipids can lead to an enrichment of lysoforms resulting from both enzymatic and non-
enzymatic hydrolysis. 
 
Figure 1: Production and structure of oxidized phospholipids and its components (modified 
after Ashraf & Srivastava, 2010; Bochkov et al. 2010). Oxidized phospholipids are generated by 
oxidation of PAPC with reactive oxygen species. Oxidation of phospholipids and subsequent reactions 
form a broad variety of oxidized phospholipids with most diverse bioactivities. 
 
Lysophospholipids can both bind and activate G protein-coupled receptors as well as 
Lysophosphatidic acid receptors 1 and 4 (LPA1 to LPA4) (Anliker and Chun, 2004; Tomura et 
al., 2005). 
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It has already been shown that OxPAPC and the component PEIPC facilitate the prostaglandin 
E2 receptor 2 and prostaglandin D2 receptor 1, leading to inflammation by mediation 
enhancement of cAMP levels (Li et al., 2006). Furthermore, OxPL and in particular its 
components PGPC and POVPC stimulate peroxisome proliferator-activated receptors (PPAR) 
and toll-like receptor 4 (Lee et al., 2000; Davies et al., 2001; Walton et al., 2003). In addition, 
OxPL have a role in interacting with scavenger receptors CD36 and SR-BI; both are important 
for the detection of apoptotic cells and the production of foam cells (Podrez et al., 2002; 
Bochkov et al., 2010).  
Mohammad Z. Ashraf and Swati Srivastava (2012). Oxidized Phospholipids: Introduction and 
Biological Significance, Lipoproteins - Role in Health and Diseases, Prof. Gerhard Kostner 
(Ed.), InTech, DOI: 10.5772/50461. Available from: 
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In summary, OxPL have a broad pharmacological spectrum and have a role in several 
receptor-mediated mechanisms with an activation of quite a few signaling pathways (Bochkov 
et al., 2010). 
 
Figure 2: Anti-inflammatory effects and mechanisms of OxPL (Bochkov et al. 2010). 
11.1 The voltage-gated sodium channel NaV1.9 
The transmission and transduction of nociceptive signals after inflammation or injury is 
depended on an enhanced excitability of sensory neurons. In this, voltage-gated sodium 
channels have a critical role. They may influence increased responsiveness to endogenous 
pronociceptive irritants such as OxPL. Voltage-gated sodium channels have a conserved 
structure of 24 transmembrane segments arranged into four homologous domains (DI-DIV). 
Each domain consists out of six transmembrane segments (S1-S6) (Catterall et al., 2005). 
There are nine genes encoding for the pore-forming alpha-subunit of the channels (SCN1A-
SCN5A; SCN8A-SCN11A). The voltage-sensing domain can be found in S4 domains, while 
the segments S5 and S6 contribute to the pore domain. The channel pore is selective for 
sodium ions.  
Nav1.8 and Nav1.9 are resistant to micromolar concentrations of TTX (TTX-R), while Nav1.1, 
Nav1.6, and Nav1.7 are inhibited by nanomolar concentrations of the neurotoxin tetrodotoxin 
(TTX-Sensitive, TTX-S). The three VGSC NaV1.7, NaV1.8 and NaV1.9 are in particular 
expressed on peripheral neurons and all three channels have been shown to have an 
important role in human pain disorders (Faber et al., 2012; Dib-Hajj et al., 2013; Huang et al., 
2013; Leipold et al., 2013; Leipold et al., 2015).  
